These confounding findings need to be explored in detail to determine the role of STAT3 in carcinogenesis of TNBC, which is defined by the lack of ER, PR and low expression of HER2 which represents about 15%–20% of breast cancers [123]. This evidence concerns the gene STAT3 and breast carcinoma.